AAV-CRISPR/Cas9介导的VEGFR2敲低在体外阻断血管生成
本体外研究采用双AAV5载体系统在人视网膜微血管内皮细胞中递送CRISPR/Cas9,在内皮特异性ICAM2启动子驱动下敲低VEGFR2,使其蛋白表达下降80%,并完全阻断VEGF诱导的Akt活化、增殖、迁移及管腔形成,作者认为该策略是病理性血管生成的潜在治疗方向。
要点
- AAV5可有效感染血管内皮细胞和视网膜色素上皮细胞。
- ICAM2启动子驱动GFP和SpCas9在人视网膜微血管内皮细胞表达,在视网膜色素上皮细胞不表达。
- rAAV5-CRISPR/Cas9使VEGFR2降低80%,并完全阻断VEGF诱导的Akt活化及增殖、迁移、管腔形成。
核心结论
- 作者认为AAV-CRISPR/Cas9介导的VEGFR2敲低是病理性血管生成的潜在治疗策略。
研究设计与样本
- 体外研究:采用源自化脓性链球菌的双AAV CRISPR/Cas9系统(AAV-SpGuide与AAV-SpCas9)编辑原代人视网膜微血管内皮细胞的基因组VEGFR2。
- 将内皮特异性ICAM2启动子克隆入SpGuide和SpCas9双AAV载体,分别驱动GFP和SpCas9表达,并包装为rAAV5感染人视网膜微血管内皮细胞。
- 采用Western blot检测蛋白表达,并检测细胞增殖、迁移及管腔形成。
主要发现
- AAV5有效感染血管内皮细胞和视网膜色素上皮细胞。
- ICAM2启动子驱动GFP和SpCas9在人视网膜微血管内皮细胞表达,但在视网膜色素上皮细胞不表达。
- rAAV5-CRISPR/Cas9使VEGFR2降低80%,并完全阻断VEGF诱导的Akt活化。
- rAAV5-CRISPR/Cas9完全阻断人视网膜微血管内皮细胞的增殖、迁移及管腔形成。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pathologic angiogenesis is a component of many diseases, including neovascular age-related macular degeneration, proliferation diabetic retinopathy, as well as tumor growth and metastasis. The purpose of this project was to examine whether the system of adeno-associated viral (AAV)-mediated CRISPR (clustered regularly interspaced short palindromic repeats)-associated endonuclease (Cas)9 can be used to deplete expression of VEGF receptor 2 (VEGFR2) in human vascular endothelial cells in vitro and thus suppress its downstream signaling events. METHODS: The dual AAV system of CRISPR/Cas9 from Streptococcus pyogenes (AAV-SpGuide and -SpCas9) was adapted to edit genomic VEGFR2 in primary human retinal microvascular endothelial cells (HRECs). In this system, the endothelial-specific promoter for intercellular adhesion molecule 2 (ICAM2) was cloned into the dual AAV vectors of SpGuide and SpCas9 for driving expression of green fluorescence protein (GFP) and SpCas9, respectively. These two AAV vectors were applied to production of recombinant AAV serotype 5 (rAAV5), which were used to infect HRECs for depletion of VEGFR2. Protein expression was determined by Western blot; and cell proliferation, migration, as well as tube formation were examined. RESULTS: AAV5 effectively infected vascular endothelial cells (ECs) and retinal pigment epithelial (RPE) cells; the ICAM2 promoter drove expression of GFP and SpCas9 in HRECs, but not in RPE cells. The results showed that the rAAV5-CRISPR/Cas9 depleted VEGFR2 by 80% and completely blocked VEGF-induced activation of Akt, and proliferation, migration as well as tube formation of HRECs. CONCLUSIONS: AAV-CRISRP/Cas9-mediated depletion of VEGFR2 is a potential therapeutic strategy for pathologic angiogenesis.
引用
- Wu W, Duan Y, Ma G, et al. AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro. Invest Ophthalmol Vis Sci. 2017. PMID: 29204648. doi:10.1167/iovs.17-21902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。